Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schaapveld

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Journal of Sleep Research|March 3, 2022
Single-item chronotype is associated with dim light melatonin onset in lymphoma survivors with fatigueLinske de Bruijn, Daniëlle E J Starreveld, Michael Schaapveld, et al.
American Journal of Surgery|August 25, 2011
Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosisMichael Schaapveld, Francisca H Jorna, Katja K H Aben, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2004
Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based studyMichael Schaapveld, Elisabeth G E de Vries, Winette T A van der Graaf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2007
Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapyWouter K de Jong, Johannes L G Blaauwgeers, Michael Schaapveld, et al.
British Journal of Haematology|October 22, 2016
Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-upLifang Liu, Francesco Giusti, Michael Schaapveld, et al.
Breast Cancer Research : BCR|March 10, 2017
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort studyLotte E Elshof, Michael Schaapveld, Emiel J Rutgers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Reply to D. Vordermark and T. Pelz and R. Mazzola et alFrederika A van Nimwegen, David J Cutter, Michael Schaapveld, et al.
Future Oncology (London, England)|December 16, 2024
An early economic evaluation of active surveillance for low-risk ductal carcinoma <i>in situ</i>Danalyn Byng, Michael Schaapveld, Esther H Lips, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2007
Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survivalLucia M A Crane, Michael Schaapveld, Otto Visser, et al.
Sleep|September 26, 2025
Quantifying cumulative circadian disruption from shift work and associations with health outcomes in a large cohort of nursesLinske de Bruijn, Michael Schaapveld, Jelle J Vlaanderen, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Journal of Sleep Research|March 3, 2022
Single-item chronotype is associated with dim light melatonin onset in lymphoma survivors with fatigueLinske de Bruijn, Daniëlle E J Starreveld, Michael Schaapveld, et al.
American Journal of Surgery|August 25, 2011
Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosisMichael Schaapveld, Francisca H Jorna, Katja K H Aben, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2004
Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based studyMichael Schaapveld, Elisabeth G E de Vries, Winette T A van der Graaf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2007
Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapyWouter K de Jong, Johannes L G Blaauwgeers, Michael Schaapveld, et al.
British Journal of Haematology|October 22, 2016
Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-upLifang Liu, Francesco Giusti, Michael Schaapveld, et al.
Breast Cancer Research : BCR|March 10, 2017
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort studyLotte E Elshof, Michael Schaapveld, Emiel J Rutgers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Reply to D. Vordermark and T. Pelz and R. Mazzola et alFrederika A van Nimwegen, David J Cutter, Michael Schaapveld, et al.
Future Oncology (London, England)|December 16, 2024
An early economic evaluation of active surveillance for low-risk ductal carcinoma <i>in situ</i>Danalyn Byng, Michael Schaapveld, Esther H Lips, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2007
Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survivalLucia M A Crane, Michael Schaapveld, Otto Visser, et al.
Sleep|September 26, 2025
Quantifying cumulative circadian disruption from shift work and associations with health outcomes in a large cohort of nursesLinske de Bruijn, Michael Schaapveld, Jelle J Vlaanderen, et al.
Pageof 14